Literature DB >> 14645355

Genetic evolution of alpha fetoprotein producing gastric cancer.

H Fujii1, K Ichikawa, T Takagaki, Y Nakanishi, M Ikegami, S Hirose, T Shimoda.   

Abstract

BACKGROUND: Alpha fetoprotein (AFP) producing gastric cancer is an unusual form of aggressive adenocarcinoma with a complex histological picture, including enteroblastic and hepatoid differentiation. AIMS: To investigate the genetic events underlying the phenotypic diversity in AFP producing gastric cancer and the ability of these tumours to produce AFP ectopically.
METHODS: Multiple foci from 19 AFP producing gastric adenocarcinomas were microdissected and loss of heterozygosity (LOH) analysis was performed with a panel of microsatellite markers on nine chromosomal arms.
RESULTS: For informative cases, LOH was most frequently detected on 17p (100%), followed by 13q (88%), 3p (87%), 5q and 9p (80%), 11q (70%), 18q (58%), 16q (53%), and 8p (50%). The average fractional allelic loss was 0.72. LOH was detected either homogeneously throughout the microdissected foci, or only in some parts of the neoplastic foci for each case. Heterogeneous patterns of LOH indicated genetic progression and/or divergence in clonal evolution. Furthermore, in six cases with heterogeneous LOH of 13q, 13q LOH was restricted to immunohistochemically AFP positive neoplastic foci.
CONCLUSION: AFP-GC arises as an aggressive clone with extensive LOH and high fractional allelic loss. The presence of heterogeneous patterns of LOH suggested that the AFP producing carcinoma foci might evolve through genetic progression and/or genetic divergence. Silencing of the crucial gene on 13q may be involved in the acquisition of the AFP producing phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645355      PMCID: PMC1770145          DOI: 10.1136/jcp.56.12.942

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  34 in total

1.  Comprehensive allelotyping of human hepatocellular carcinoma.

Authors:  H Nagai; P Pineau; P Tiollais; M A Buendia; A Dejean
Journal:  Oncogene       Date:  1997-06-19       Impact factor: 9.867

Review 2.  Clear cell tumors of the alimentary tract and abdominal cavity.

Authors:  J H Ritter; S E Mills; M J Gaffey; O Nappi; M R Wick
Journal:  Semin Diagn Pathol       Date:  1997-08       Impact factor: 3.464

3.  Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.

Authors:  G H Kang; Y I Kim
Journal:  Virchows Arch       Date:  1998-01       Impact factor: 4.064

4.  Allelotype analysis of hepatocellular carcinoma.

Authors:  Z Piao; C Park; J H Park; H Kim
Journal:  Int J Cancer       Date:  1998-01-05       Impact factor: 7.396

5.  Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.

Authors:  S Nishizuka; G Tamura; M Terashima; R Satodate
Journal:  J Pathol       Date:  1998-05       Impact factor: 7.996

6.  Clear cell carcinomas of the gallbladder and extrahepatic bile ducts.

Authors:  C Vardaman; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394

7.  Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production.

Authors:  Y Hoshida; T Nagakawa; S Mano; K Taguchi; K Aozasa
Journal:  Int J Gynecol Pathol       Date:  1996-07       Impact factor: 2.762

8.  Fractional allelic loss in gastric carcinoma correlates with growth patterns.

Authors:  S W Choi; S W Park; K Y Lee; K M Kim; Y J Chung; M G Rhyu
Journal:  Oncogene       Date:  1998-11-19       Impact factor: 9.867

9.  Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.

Authors:  J H Cho; M Noguchi; A Ochiai; S Hirohashi
Journal:  Lab Invest       Date:  1996-04       Impact factor: 5.662

10.  Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.

Authors:  T Kuroki; Y Fujiwara; S Nakamori; S Imaoka; T Kanematsu; Y Nakamura
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more
  17 in total

Review 1.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  An Alpha Fetoprotein Producing Gastric Tumor with Yolk Sac, Hepatoid and Papillary Adenocarcinoma Components.

Authors:  Archana Lakshmanan; Ann Kurian; Annapurneswari Subramanyan; Ayyappan Srinivasan
Journal:  J Clin Diagn Res       Date:  2017-09-01

3.  Protein induced by vitamin K absence or antagonist II-producing gastric cancer.

Authors:  Yoshihisa Takahashi; Tohru Inoue; Toshio Fukusato
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

4.  Metastatic splenic α-fetoprotein-producing adenocarcinoma: report of a case.

Authors:  Zhigang Deng; Zhenyu Yin; Shouhui Chen; Youyuan Peng; Fuqiang Wang; Xiaomin Wang
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

5.  Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report.

Authors:  Tiago Biachi de Castria; Laura Tang; Marcello Moro Queiroz; Beatriz Mendes Awni; Viktoriya Paroder; Ali Shamseddine; Giovanni Mendonca Bariani; Deborah Mukherji; Charbel F Matar; Gustavo Dos Santos Fernandes; Ashwaq El-Olayan; Fouad Sabatin; Rawad Elias; Ranju Gupta; Yelena Y Janjigian; Ghassan K Abou-Alfa
Journal:  J Gastrointest Oncol       Date:  2021-12

6.  HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.

Authors:  Hao Xu; Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Yong-Xi Song; Jin-Yu Huang; Jun-Yan Zhang; Xing-Yu Liu; Jian-Hua Wu; Hui-Mian Xu
Journal:  Virchows Arch       Date:  2017-09-29       Impact factor: 4.064

7.  Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report.

Authors:  Shigetomi Nakao; Bunzo Nakata; Masashige Tendo; Kenji Kuroda; Takeshi Hori; Mayumi Inaba; Kosei Hirakawa; Tetsuro Ishikawa
Journal:  BMC Surg       Date:  2015-01-16       Impact factor: 2.102

Review 8.  Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge.

Authors:  Jon Arne Søreide; Ole Jacob Greve; Einar Gudlaugsson; Svein Størset
Journal:  Scand J Gastroenterol       Date:  2016-01-05       Impact factor: 2.423

9.  The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.

Authors:  Kai Zhou; Anqiang Wang; Sheng Ao; Jiahui Chen; Ke Ji; Qifei He; Xin Ji; Xiaojiang Wu; Ji Zhang; Zhongwu Li; Zhaode Bu; Jiafu Ji
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

10.  Gastrointestinal Obstruction due to Solitary Lymph Node Recurrence of Alpha-Fetoprotein-Producing Gastric Carcinoma with Enteroblastic Differentiation.

Authors:  Takumi Yamabuki; Makoto Omi; Atsuya Yonemori; Kenjiro Misu; Hitoshi Inomata; Yukie Abiko; Michio Mori; Kazuyoshi Nihei
Journal:  Case Rep Gastroenterol       Date:  2014-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.